The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak

In response to the 2011 European health alert caused by a pathogenic Escherichia coli O104:H4 outbreak, the European Academy of Microbiology (EAM), established by the Federation of European Microbiological Societies (FEMS), convened a meeting in Paris on November 30th, 2011 on ‘EHEC infection and control’ attended by world renowned experts in pathogenic E. coli. The major aims of this group were to review the scientific issues raised by the outbreak, to assess the handling of the crisis at the scientific and political levels, and to propose future actions. Several conclusions, which will have impact on future potential E. coli outbreaks, are outlined here.

[1]  É. Oswald,et al.  French cattle is not a reservoir of the highly virulent enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4. , 2012, Veterinary microbiology.

[2]  Craig S. Wong,et al.  Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Mellmann,et al.  Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 Strain , 2012, Antimicrobial Agents and Chemotherapy.

[4]  Eric S. Lander,et al.  Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011 , 2012, Proceedings of the National Academy of Sciences.

[5]  A. Linstedt,et al.  Manganese Blocks Intracellular Trafficking of Shiga Toxin and Protects Against Shiga Toxicosis , 2012, Science.

[6]  J. Blanco,et al.  Characteristics of the Shiga-toxin-producing enteroaggregative Escherichia coli O104:H4 German outbreak strain and of STEC strains isolated in Spain. , 2011, International microbiology : the official journal of the Spanish Society for Microbiology.

[7]  Matthias Greiner,et al.  German outbreak of Escherichia coli O104:H4 associated with sprouts. , 2011, The New England journal of medicine.

[8]  Klaus Stark,et al.  Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. , 2011, The New England journal of medicine.

[9]  H. Karch,et al.  No evidence of the Shiga toxin-producing E. coli O104:H4 outbreak strain or enteroaggregative E. coli (EAEC) found in cattle faeces in northern Germany, the hotspot of the 2011 HUS outbreak area , 2011, Gut pathogens.

[10]  S. Felix,et al.  Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial , 2011, The Lancet.

[11]  A. Mellmann,et al.  Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. , 2011, The Lancet. Infectious diseases.

[12]  Junhua Li,et al.  Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. , 2011, The New England journal of medicine.

[13]  James H. Bullard,et al.  Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. , 2011, The New England journal of medicine.

[14]  E. Denamur.  The 2011 Shiga toxin-producing Escherichia coli O104:H4 German outbreak: a lesson in genomic plasticity. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  J. Rothberg,et al.  Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology , 2011, PloS one.

[16]  E. Brzuszkiewicz,et al.  Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC) , 2011, Archives of Microbiology.

[17]  Snedeker,et al.  The new face of enterohaemorrhagic Escherichia coli infections. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  B. Finlay,et al.  Vaccination with type III secreted proteins leads to decreased shedding in calves after experimental infection with Escherichia coli O157. , 2011, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[19]  G. Storz,et al.  Bacterial Stress Responses, Second Edition , 2011 .

[20]  J. Avorn.  Eculizumab in Severe Shiga-Toxin-Associated HUS , 2011 .

[21]  G. Storz,et al.  Bacterial stress responses. , 2011 .

[22]  J. Wain,et al.  Multi-Locus Sequence Typing of Enteroaggregative Escherichia coli Isolates from Nigerian Children Uncovers Multiple Lineages , 2010, PloS one.

[23]  L. Johannes,et al.  Inhibition of Retrograde Transport Protects Mice from Lethal Ricin Challenge , 2010, Cell.

[24]  M. Seaman,et al.  Ricin Toxin Hits a Retrograde Roadblock , 2010, Cell.

[25]  Petra Schwille,et al.  GM1 structure determines SV40-induced membrane invagination and infection , 2010, Nature Cell Biology.

[26]  B. Finlay,et al.  Molecular mechanisms of Escherichia coli pathogenicity , 2012, Nature Reviews Microbiology.

[27]  B. Hurault de Ligny,et al.  Safety and Long‐Term Efficacy of Eculizumab in a Renal Transplant Patient with Recurrent Atypical Hemolytic–Uremic Syndrome , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  A. Danchin,et al.  Organised Genome Dynamics in the Escherichia coli Species Results in Highly Diverse Adaptive Paths , 2009, PLoS genetics.

[29]  A. Mellmann,et al.  Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.

[30]  Katharina Gaus,et al.  Shiga toxin induces tubular membrane invaginations for its uptake into cells , 2007, Nature.

[31]  J. Nataro,et al.  Pathogenesis of enteroaggregative Escherichia coli infection. , 2006, FEMS microbiology letters.

[32]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[33]  P. Nordmann,et al.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3 , 2002 .

[34]  P. Nordmann,et al.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. , 2002, The Journal of antimicrobial chemotherapy.

[35]  C. Harwood,et al.  Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. , 2000, Emerging infectious diseases.

[36]  M. McKee,et al.  The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. , 1993, The Journal of clinical investigation.

[37]  A. Pugsley.  Shiga toxin. , 1986, Microbiological sciences.